A phase II trial of induction Erlotinib followed by chemotherapy with Platinum + Pemetrexed +/- Bevacizumab for EGFR mutation-positive non-squamous non-small cell lung cancer patients.

Tetsuo Tani, Tomoko Betsuyaku, Keiko Ohgino et al.|Journal of Clinical Oncology|2015

Cited by 0